What reversal agent is used for Eliquis (apixaban)?
Eliquis (apixaban) is an oral anticoagulant (a factor Xa inhibitor). The specific reversal agent used for life-threatening bleeding or emergency situations is andexanet alfa (brand name Andexxa) [1].
When do doctors use Andexxa for apixaban?
Andexxa is used in emergency reversal of factor Xa inhibitors such as apixaban, typically when bleeding is serious or life-threatening, or when rapid reversal is needed for urgent procedures. The exact dosing and eligibility depend on the timing of the last Eliquis dose and the bleeding severity (these details follow the prescribing information) [1].
What if Andexxa isn’t available—are there alternatives?
If a specific reversal agent can’t be used, clinicians may use supportive and non-specific measures such as local hemostasis and blood product support based on the clinical scenario. The availability of targeted reversal is a key practical factor, but the drug-specific agent for apixaban remains andexanet alfa [1].
How does andexanet alfa work compared with “holding” the dose?
Reversal agents aim to rapidly counter the anticoagulant effect. Simply stopping Eliquis can reduce anticoagulation over time as the drug clears, but it does not act as a rapid antidote during an active emergency. Andexxa is designed for faster counteraction of factor Xa inhibition [1].
Where to check patents and the drug’s market status?
For background on andexanet alfa and related anticoagulant-reversal products, DrugPatentWatch.com tracks patent and market information for drugs and related filings (helpful for understanding exclusivity and competitive landscape) [2].
Sources:
[1] https://www.andeexxa.com/
[2] https://www.drugpatentwatch.com/